NCT05677607

Brief Summary

The present study aims at verifying the mutual effects between intracranial large artery atherosclerosis and cerebral small vessel disease on disease progression and prognosis by magnetic resonance imaging, and providing biomarkers for the early prevention and treatment of cerebrovascular disease.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
20mo left

Started Jan 2023

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress67%
Jan 2023Dec 2027

First Submitted

Initial submission to the registry

December 19, 2022

Completed
13 days until next milestone

Study Start

First participant enrolled

January 1, 2023

Completed
9 days until next milestone

First Posted

Study publicly available on registry

January 10, 2023

Completed
5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2027

Last Updated

July 3, 2024

Status Verified

June 1, 2024

Enrollment Period

5 years

First QC Date

December 19, 2022

Last Update Submit

June 30, 2024

Conditions

Keywords

Intracranial atherosclerosisCerebral small vessel diseaseFeedback mechanismMultimodal MRI

Outcome Measures

Primary Outcomes (2)

  • Progression in total cerebral small vessel disease burden

    Total cerebral small vessel disease burden is assessed according to a sum of scores of white matter hyperintensity, cerebral microbleeds, lacunes and enlarged perivasular spaces on magnetic resonance imaging sequences.

    1-3 YEARS

  • Frequency of stroke recurrence

    The percentage of symptomatic participants who suffer from stroke recurrence after enrollment in the territory of the targeted stenotic vessel.

    1-3 YEARS

Secondary Outcomes (1)

  • Frequency of stroke of asymptomatic participants

    1-3 YEARS

Study Arms (1)

Intracranial atherosclerosis and small vessel disease

Patients diagnosed with intracranial large artery atherosclerosis and cerebral small vessel disease based on imaging screening.

Diagnostic Test: Magnetic resonance imaging

Interventions

Imaging diagnostics mainly based on Magnetic resonance imaging.

Intracranial atherosclerosis and small vessel disease

Eligibility Criteria

Age30 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Participants with at least on intracranial artery ≥ 50% atherosclerotic stenosis.

You may qualify if:

  • Age ≥ 18 years
  • At least one intracranial artery ≥ 50% atherosclerotic stenosis
  • Modified Rankin Scale \< 2
  • Mini-mental State Examination \> 24

You may not qualify if:

  • Concurrent ipsilateral extracranial artery ≥ 50% stenosis
  • Pregnant women
  • Contraindications to magnetic resonance examination (patients with pacemakers, nerve stimulators, artificial metal heart valves and other metal foreign bodies)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chinese PLA General Hospital

Beijing, Beijing Municipality, 100853, China

RECRUITING

MeSH Terms

Conditions

Intracranial ArteriosclerosisCerebral Small Vessel Diseases

Interventions

Magnetic Resonance Imaging

Condition Hierarchy (Ancestors)

Intracranial Arterial DiseasesCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesArteriosclerosisArterial Occlusive DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

TomographyDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosis

Study Officials

  • Jinhao Lyu

    Chinese PLA General Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Attending physician

Study Record Dates

First Submitted

December 19, 2022

First Posted

January 10, 2023

Study Start

January 1, 2023

Primary Completion (Estimated)

December 31, 2027

Study Completion (Estimated)

December 31, 2027

Last Updated

July 3, 2024

Record last verified: 2024-06

Data Sharing

IPD Sharing
Will not share

Locations